GCGabriela Carla dos Santos Costa

Gabriela Carla dos Santos Costa

*This is an algorithmically generated author record based on publicly available information.

Gabriela Carla dos Santos Costa has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Associations between obesity and severity of coronavirus disease 2019 in Brazilian inpatients: A 2021 secondary data analysis

    by Gabrielle Ribeiro Sena, Tiago Pessoa Ferreira de Lima, Michelle Lima de Carvalho Silva, Paloma Gomes Tavares Sette, Gabriela Carla dos Santos Costa, Amanda Mendes da Fonseca Benvindo, Maria Júlia Gonçalves de Mello, Guilherme Jorge Costa

    Summary: In the backdrop of the global obesity pandemic, recognized as a notable risk factor for coronavirus disease 2019 (COVID‐19) complications, the study aims to explore clinical and epidemiological attributes of hospitalized COVID‐19 patients throughout 2021 in Brazil. Focused on four distinct age cohorts, the investigation scrutinizes parameters such as intensive care unit (ICU) admission frequency, invasive mechanical ventilation (IMV) usage, and in‐hospital mortality among individuals with and without obesity. Using a comprehensive cross‐sectional study methodology, encompassing adult COVID‐19 cases, data sourced from the Influenza Epidemiological Surveillance Information System comprises 329 206 hospitalized patients. Of these individuals, 26.3% were affected by obesity. Analysis reveals elevated rates of ICU admissions, increased dependence on IMV, and heightened in‐hospital mortality among the individuals with obesity across all age groups (p < .001). Logistic regression, adjusting for confounding variables, underscores a progressively rising odds ratio for mortality in younger age brackets: 1.2 (95%CI 1.1–1.3) for those under 50 years, 1.1 (95%CI 1.0–1.2) for the 50–59 age group, and 1.1 (95%CI 1.0–1.2) for the 60–69 age group. Conversely, no significant mortality difference is observed for patients over 70 years (OR: 0.972, 95%CI 0.9–1.1). In summary, hospitalized COVID‐19 patients with obesity, particularly in younger age groups, exhibit elevated rates of ICU admission, IMV requirement, and in‐hospital mortality compared with the control group. Notably, the ‘obesity paradox’ is not evident among hospitalized COVID‐19 patients in 2021.


  • Open Access

    Síndrome pós-COVID-19 e qualidade de vida em mulheres

    by Mariana Lúcia Correia Ramos Costa, Marcela Rezende Franco, Camila Menezes Costa, Gabriela Carla dos Santos Costa, Maria Luiza de Queiroz Neta, Lívia Barboza de Andrade, Guilherme Jorge Costa

    Resumo Objectives: to determine the clinical and epidemiological profile of the long post-COVID syndrome (LPCS) and the quality of life among female survivors compared to males after hospitalization for COVID-19 in the city of Recife, Brazil. Methods: a prospective cohort study analyzed demographic and clinical data during hospitalization, as well as LPCS and the quality of life questionnairewhereasdata was collected by telecare at three, sixand 12 months after hospital discharge. Logistic regression was used to explore the association between variables and each dimension of the questionnaire. Results: 887 patients were included. At the end of three, sixand 12 months, women were more frequently reported with LPCS (p<0.001). Regarding quality of life, women tended to worsen over time in all domains compared to men: mobility domain (28.4% versus 9.3%, p<0.05), personal care (14.8% versus 5.6%; p<0.05), usual activities (30.8% versus 13.1%, p < 0.05), pain/discomfort (29% versus 16.9%, p<0.05) and anxiety/depression (43.8% versus 33.3%, p<0.05). Conclusion: the frequency of LPCS increased and the quality of life worsened with both genders until the first year after hospital discharge, especially in women.

  • Open Access

    Post-COVID 19 syndrome and quality of life in women

    by Mariana Lúcia Correia Ramos Costa, Marcela Rezende Franco, Camila Menezes Costa, Gabriela Carla dos Santos Costa, Maria Luiza de Queiroz Neta, Lívia Barboza de Andrade, Guilherme Jorge Costa

    Objectives: to determine the clinical and epidemiological profile of the long post-COVID syndrome (LPCS) and the quality of life among female survivors compared to males after hospitalization for COVID-19 in the city of Recife, Brazil. Methods: a prospective cohort study analyzed demographic and clinical data during hospitalization, as well as LPCS and the quality of life questionnairewhereasdata was collected by telecare at three, sixand 12 months after hospital discharge. Logistic regression was used to explore the association between variables and each dimension of the questionnaire. Results: 887 patients were included. At the end of three, sixand 12 months, women were more frequently reported with LPCS (p<0.001). Regarding quality of life, women tended to worsen over time in all domains compared to men: mobility domain (28.4% versus 9.3%, p<0.05), personal care (14.8% versus 5.6%; p<0.05), usual activities (30.8% versus 13.1%, p < 0.05), pain/discomfort (29% versus 16.9%, p<0.05) and anxiety/depression (43.8% versus 33.3%, p<0.05). Conclusion: the frequency of LPCS increased and the quality of life worsened with both genders until the first year after hospital discharge, especially in women.

  • Open Access

    Risk factors for death and illness severity in vaccinated versus unvaccinated COVID-2019 inpatients: a retrospective cohort study

    by Guilherme Jorge Costa, José Roberto da Silva Junior, Caio Cesar Arruda da Silva, Tiago Pessoa Ferreira de Lima, Mariana Menezes Costa, Marcos Henrique Oliveira Sousa, Gabriela Carla Dos Santos Costa, José Iran Costa Júnior, Mozart Júlio Tabosa Sales

    Objective: To determine the clinical profile of COVID-19 inpatients who were vaccinated prior to hospitalization and to compare the risk factors for death and the 28-day survival rate of between those inpatients vaccinated with one, two, or three doses and unvaccinated COVID-19 inpatients. Methods: This was a retrospective observational cohort study involving COVID-19 patients admitted to a referral hospital in the city of Recife, Brazil, between July of 2020 and June of 2022. Results: The sample comprised 1,921 inpatients, 996 of whom (50.8%) were vaccinated prior to hospitalization. After adjusting the mortality risk for vaccinated patients, those undergoing invasive mechanical ventilation (IMV) had the highest mortality risk (adjusted OR [aOR] = 7.4; 95% CI, 3.8-14.1; p < 0.001), followed by patients > 80 years of age (aOR = 7.3; 95% CI, 3.4-15.4; p < 0.001), and those needing vasopressors (aOR = 5.6; 95% CI, 2.9-10.9; p < 0.001). After adjusting the mortality risk for all patients, having received three vaccine doses (aOR = 0.06; 95% CI, 0.03-0.11; p < 0.001) was the most important protective factor against death. There were progressive benefits of vaccination, reducing the frequency of ICU admissions, use for IMV, and death (respectively, from 44.9%, 39.0% and 39.9% after the first dose to 16.7%, 6.2% and 4.4% after the third dose), as well as significant improvements in survival after each subsequent dose (p < 0.001). Conclusions: Vaccines were effective in reducing illness severity and death in this cohort of COVID-19 inpatients, and the administration of additional doses conferred them with accumulative vaccine protection.